share_log

Dawson James Initiates Coverage On Zomedica With Buy Rating, Announces Price Target of $6

Dawson James Initiates Coverage On Zomedica With Buy Rating, Announces Price Target of $6

道森·詹姆斯以买入评级启动对Zomedica的报道,宣布目标股价为6美元
Benzinga Real-time News ·  2023/01/06 08:27

Dawson James analyst Jason Kolbert initiates coverage on Zomedica (AMEX:ZOM) with a Buy rating and announces Price Target of $6.

道森·詹姆斯分析师杰森·科尔伯特开始报道Zomedica(AMEX: ZOM),评级为买入,并宣布目标股价为6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发